Relay Therapeutics Inc

Relay Therapeutics is a biotechnology company whose drug discovery platform and research pipeline rely on animal testing. The company’s core business involves using animal models to validate drug targets and test preclinical candidates, a standard but material practice in the pharmaceutical industry. This reliance places animal use at the center of its research and development operations.

Cruelty Free Investors has flagged the company for investor concern regarding animal welfare as a material business issue. The available evidence indicates a reliance on animal models but does not provide specific details on the scale, species used, or internal welfare standards. Without further public disclosure from the company on its animal use policies, oversight, or commitment to alternative methods, the reliance on animal testing constitutes a commercial exploitation of animals under this broad exclusion category.